Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Beijing 302 Hospital
First People's Hospital of Hangzhou
H. Lee Moffitt Cancer Center and Research Institute
Medical College of Wisconsin
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Alabama at Birmingham
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Dartmouth-Hitchcock Medical Center
City of Hope Medical Center
Washington University School of Medicine
Astellas Pharma Inc
St. Jude Children's Research Hospital
City of Hope Medical Center
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Astellas Pharma Inc
Washington University School of Medicine
M.D. Anderson Cancer Center
Astellas Pharma Inc
Children's Hospital Medical Center, Cincinnati
Fred Hutchinson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Memorial Sloan Kettering Cancer Center
Sunshine Lake Pharma Co., Ltd.
The First Affiliated Hospital of Xiamen University
Northwestern University
Nanfang Hospital, Southern Medical University
Beijing 302 Hospital
Shanxi Bethune Hospital
Medical College of Wisconsin
Children's Hospital of Soochow University
Medical College of Wisconsin
The Second People's Hospital of Huai'an
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
University of Nebraska
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)